pentoxifylline has been researched along with Colorectal Neoplasms in 4 studies
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the hypothesis that preincisional IV pentoxifylline (PTX) treatment could attenuate the release of proinflammatory (tumor necrosis factor, interleukin (IL)-1beta, IL-6, and IL-8) and antiinflammatory (IL-1 receptor antagonist) cytokines in patients who underwent elective colorectal cancer surgery." | 9.11 | Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery. ( Borel, CO; Chao, PC; Lu, CH; Wong, CS; Wu, CT; Yang, CP; Yeh, CC, 2004) |
| " We investigated the hypothesis that preincisional IV pentoxifylline (PTX) treatment could attenuate the release of proinflammatory (tumor necrosis factor, interleukin (IL)-1beta, IL-6, and IL-8) and antiinflammatory (IL-1 receptor antagonist) cytokines in patients who underwent elective colorectal cancer surgery." | 5.11 | Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery. ( Borel, CO; Chao, PC; Lu, CH; Wong, CS; Wu, CT; Yang, CP; Yeh, CC, 2004) |
| "Patients with liver metastases from colorectal carcinoma who were scheduled for local ablation by radiotherapy (image-guided high-dose-rate interstitial brachytherapy) were prospectively randomized to receive PTX, UDCA and LMWH for 8 weeks (treatment) or no medication (control)." | 2.79 | Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity. ( Damm, R; Gademann, G; Hass, P; Kropf, S; Mohnike, K; Pech, M; Ricke, J; Sangro, B; Seidensticker, M; Seidensticker, R; Wust, P, 2014) |
| "RNA sequencing of primary colorectal cancer specimens vs adjacent liver tissue vs synchronous and asynchronous liver metastases." | 1.91 | Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids. ( Blandino, G; Canu, V; Caricato, M; Cioce, M; Crescenzi, A; Diodoro, MG; Donzelli, S; Fanciulli, M; Fazio, VM; Fumagalli, MR; Goeman, F; Grazi, GL; La Porta, C; Levrero, M; Morrone, A; Orlandi, G; Palcau, AC; Pulito, C; Rutigliano, D; Sacconi, A; Strano, S; Verri, M; Zapperi, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cioce, M | 1 |
| Fumagalli, MR | 1 |
| Donzelli, S | 1 |
| Goeman, F | 1 |
| Canu, V | 1 |
| Rutigliano, D | 1 |
| Orlandi, G | 1 |
| Sacconi, A | 1 |
| Pulito, C | 1 |
| Palcau, AC | 1 |
| Fanciulli, M | 1 |
| Morrone, A | 1 |
| Diodoro, MG | 1 |
| Caricato, M | 1 |
| Crescenzi, A | 1 |
| Verri, M | 1 |
| Fazio, VM | 1 |
| Zapperi, S | 1 |
| Levrero, M | 1 |
| Strano, S | 1 |
| Grazi, GL | 1 |
| La Porta, C | 1 |
| Blandino, G | 1 |
| Seidensticker, M | 1 |
| Seidensticker, R | 1 |
| Damm, R | 1 |
| Mohnike, K | 1 |
| Pech, M | 1 |
| Sangro, B | 1 |
| Hass, P | 1 |
| Wust, P | 1 |
| Kropf, S | 1 |
| Gademann, G | 1 |
| Ricke, J | 1 |
| Lu, CH | 1 |
| Chao, PC | 1 |
| Borel, CO | 1 |
| Yang, CP | 1 |
| Yeh, CC | 1 |
| Wong, CS | 1 |
| Wu, CT | 1 |
| Tuckey, JA | 1 |
| Parry, BR | 1 |
| McCall, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity After Brachytherapy of Liver Metastases From Colorectal Carcinoma, Assessed in a Prospective Randomised Trial[NCT01149304] | Phase 2 | 22 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for pentoxifylline and Colorectal Neoplasms
| Article | Year |
|---|---|
Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Enoxaparin; Female; Humans; Liver Neop | 2014 |
Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery.
Topics: Adult; Aged; Aged, 80 and over; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthesia, Gener | 2004 |
Pentoxifylline and wellbeing in cancer.
Topics: Colorectal Neoplasms; Fatigue; Gastrointestinal Neoplasms; Humans; Pentoxifylline; Quality of Life; | 1993 |
1 other study available for pentoxifylline and Colorectal Neoplasms
| Article | Year |
|---|---|
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
Topics: Colorectal Neoplasms; Fluorouracil; Humans; Interleukin-6; Liver Neoplasms; Organoids; Pentoxifyllin | 2023 |